Australia awaits US FDA reports on ADHD drugs ( United States has asked the US Food and...)

Australia awaits US FDA reports on ADHD drugs

United States has asked the US Food and Drug Administration to study the safety of the drugs used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) following reports that the drug usage // causes cardiovascular diseases such as strokes and heart attacks. The US committee would meet on starting of february to review the safety of ADHD drugs. The Therapeutic Goods Administration (TGA) in Australia is responsible for the safety of drugs and has said that the TGA // would take action after the US committee submits its review report and TGA feels that it is not going to start a separate enquiry to investigate the drug action but , had asked their countries physicians to report of any adverse effects reported by their patients taking this drug. Dexamphetamine sulphate is the mostly used ADHD drug and it is widely used in Australia.

Page: 1
Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia to Show Leniency towards U.S. Pharmaceutical Companies
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors

Post Your Comments:

(Date:11/9/2009)... , Tarkett Sports, the wo...orth American indoor product offering with a more ...ptions, a new team of indoor sports flooring exper.... , (PRWEB) November 9, 2...erican indoor sports flooring products includes ha...

(Date:11/9/2009)... , SHENZHEN, China, Nov. 9 /PRNewswire-As...ited (NYSE: MR ), a leading developer, manufactur...unced today its selected unaudited,financial resul...tember 30,2009. , , Highlights for Operations...9 net revenues were $151.1 million, an increase of...

(Date:11/9/2009)... , WASHINGTON, Nov. 9 The C...estow its Award For Leadership to J.W. "Bill" Marr...cracy through progressive free market practices an...s culture. Mr. Marriott will receive his award at ...he Washington D.C. Four Seasons Hotel. ,, "Thi...

(Date:11/9/2009)... Result may be left atrial enlargement, study fin...- Obesity is a major risk factor for left atrial e...rillation, stroke and death, a new study shows. ,...arrhythmia (an irregular heart rhythm or heartbeat...d women, aged 25 to 74, in Germany who were follow...

(Date:11/9/2009)... Link likely due to fact that both eye conditions...NDAY, Nov. 9 (HealthDay News) -- Cataract surgery ...ated macular degeneration (AMD), according to a ne...ne cause of vision loss worsens the other. , "B...any individuals with cataract also have AMD," wrot...

[0] Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website [0] Mindray Announces Third Quarter 2009 Financial Results [0] J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership [0] Obesity Seems to Alter Heart Structure [0] Cataract Surgery Doesn't Worsen Macular Degeneration: Study

... more complete picture of color vision evolution h...li to an up-close, genetic encounter with one of t... , Verrelli and his ASU team have performed the f...al features including extremely large eyes and ear...

...e age of 5 who receive an annual flu shot have a g... or be admitted to the hospital because of flu-rel...of Pediatrics that analyzes how many outpatient vi... as 650,000 doctors office visits and 2,250 hospit...

... 4 "Biotech rode a surging market,in the final tr... Day,holiday weekend," said G. Steven Burrill, CEO...leader in life sciences whose principal activities...SDAQ,s 2% increase." Driving the Burrill Biotech ...

...Sept. 4 Approximately 85,percent of the 8 million...y,Disorder (AD/HD) remain undiagnosed due to a lac... this neurobiological disorder. Without proper,med...g of the disorder and provide hope to,people with ...

...forts to control it, diarrhoea is still one of the...rates in many low and middle-income countries. Thi...nted at the Swedish medical university Karolinska ...any years, Chief physician Birger Forsberg has bee...

...rbett Worldwide Healthcare,Communications has been...udging Event in the U.S. Robin Shapiro, Senior Vic...rbett, will serve as the Host Judge.,Corbett is th... of Corbett.,"The Global Awards is one of the most...

Other Medicine News:Health News:The aye-ayes have it: The preservation of color vision in a creature of the night 2 Health News:The aye-ayes have it: The preservation of color vision in a creature of the night 3 Health News:Annual flu shot cuts need for doctors' visits, hospitalization among children 2 Health News:Biotech Finishes on a High in August, Burrill Report Says 2 Health News:Biotech Finishes on a High in August, Burrill Report Says 3 Health News:Biotech Finishes on a High in August, Burrill Report Says 4 Health News:Biotech Finishes on a High in August, Burrill Report Says 5 Health News:ADDA'S Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them 2 Health News:ADDA'S Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them 3 Health News:1.5 million children could be saved 2 Health News:Corbett Selected to Host the Only Midwest Global Awards Judging Competition 2

The aye-ayes have it: The preservation of color vision in a creature of the night Annual flu shot cuts need for doctors' visits, hospitalization among children Biotech Finishes on a High in August, Burrill Report Says ADDA'S Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them 1.5 million children could be saved Corbett Selected to Host the Only Midwest Global Awards Judging Competition

(Date:11/9/2009)..., WALTHAM, Mass., Nov. 9 Decisio...nd advisory firms for pharmaceutical and healthcar...wth factor receptor 2 (HER2) targeting therapies -...SmithKline/Nippon Kayaku,s Tykerb/Tyverb -- were t...atment. Continued uptake of Herceptin and Tykerb/T...

(Date:11/9/2009)..., SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCal...harmaceutical company focused on developing and co...the treatment of immune mediated diseases and canc...sident, Preclinical Development will provide an ov... Merriman Curhan Ford,s 6th Annual Investor Summit...

(Date:11/9/2009)..., GLEN ROCK, Pa., Nov. 9 ARmark ...c. announced today an alliance in the development ...M) , an authentication technology that incorporate...-release film coatings of solid oral dosage forms ...ovides Colorcon exclusive rights to market ARmark,...

Breaking Medicine Technology:Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2 Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2 ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2 ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3 Study reveals new role of vitamin C in skin protection 56591 1 Study reveals new role of vitamin C in skin protection 56591 2 UAB researchers find TB prevention therapy is cost effective option 56588 1 UAB researchers find TB prevention therapy is cost effective option 56588 2 Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 1 Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 2

[0] Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 [0] Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 [0] ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance

...ng and Webcast to Follow,Presentation, DANBURY, Co...l,Inc. today announced plans to present clinical r...M), at the 67th Annual American,Diabetes Associati...o, June 22 through June 26. , Biodel,s oral presen...4:15 - 6:15pm CST, a summary of which will be avai...

...wire-FirstCall/ -- Orexigen(TM),Therapeutics, Inc....tment of central nervous system disorders with an ... Company will present data,about its lead obesity ...arkers of cardiovascular disease (visceral fat, se...sistance. The,findings come from additional analys...

Other Medicine Technology:Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 2 Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 3 Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2 Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3

Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23

AQuify Long-Lasting Comfort Drops

Lens Plus Rewetting Drops

Renu Rewetting Drops

Renu Multiplus Lubricating and Rewetting Drops

Medicine Products:

AQuify Long-Lasting Comfort Drops Lens Plus Rewetting Drops Renu Rewetting Drops Renu Multiplus Lubricating and Rewetting Drops

( United States has asked the US Food and...)Australia awaits US FDA reports on ADHD drugs,Health